Anthrogen is a Biotechnology Research firm using bacteria and enzymes for reducing carbon in the air by transforming it into chemicals.
Anthrogen has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in November 2024.
Anthrogen's investors include Y Combinator, BoxGroup, Pioneer Fund, Liquid 2 Ventures, Wayfinder Ventures.
Anthrogen is headquartered in San Francisco, United States.
Anthrogen is a Biotechnology Research firm using bacteria and enzymes for reducing carbon in the air by transforming it into chemicals.
Anthrogen is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Anthrogen — Funding & Investors." VCBacked, November 12, 2024, https://www.vcbacked.co/company/anthrogen. Accessed July 19, 2026.
VCBacked. (2024). Anthrogen — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/anthrogen
{{cite web |title=Anthrogen — Funding & Investors |url=https://www.vcbacked.co/company/anthrogen |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated